-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on IO Biotech, Lowers Price Target to $3

Benzinga·10/22/2025 15:26:34
Listen to the news
Piper Sandler analyst Allison Bratzel maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target from $10 to $3.